JNJ-2113 Icotrokinra
JNJ-77242113/JNJ-2113/PN-235(白细胞介素23受体抑制剂)
Ac-Pen-Asn-Thr-Trp(7-Me)-Lys(Ac)-Pen-Phe(4-amino ethoxy)-2Nal-ThpGly-Glu-Asn-3Pal-Sar-NH2 (Pen1&Pen6 bridge)
2763602-16-8
By achieving highly selective blockade of IL-23R with high binding affinity (KD=7.1 pM), it inhibits the inflammatory signaling pathway
JNJ-77242113-AAC Tablet
Semaglutide API has the following four characteristics:High Quality, Low Cost, Large Capacity, Complete Dossier. Semaglutide API is well received favourable reviews in the pharmaceutical industry of polypeptide .
At present, 13 production lines have been built, including 7 production lines for the preparation of recombinant peptide API and fully synthetic peptide API and 6 lines for injections.
The company covers a total area of 55 mu, with a total construction area of about 70,000 square meters, and has built about 800 square meters of R & D center, 1,000 square meters of quality control center and 3,300 square meters of GMP production workshop.
Our professional team collaborate and communicate effectively with one another, and are committed to delivering high-quality results. They are capable of handling complex challenges and projects that require their specialized expertise and experience.
الوسم : JNJ-2113 Icotrokinra, China JNJ-2113 Icotrokinra manufacturers, suppliers, factory
You Might Also Like
إرسال التحقيق